297 related articles for article (PubMed ID: 29378858)
1. Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease.
Taylor EB; Barati MT; Powell DW; Turbeville HR; Ryan MJ
Hypertension; 2018 Apr; 71(4):719-728. PubMed ID: 29378858
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease.
Taylor EB; Ryan MJ
J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242635
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus.
Wolf VL; Taylor EB; Ryan MJ
Physiol Rep; 2019 May; 7(10):e14059. PubMed ID: 31124322
[TBL] [Abstract][Full Text] [Related]
4. Temporal hemodynamic changes in a female mouse model of systemic lupus erythematosus.
Dent EL; Taylor EB; Sasser JM; Ryan MJ
Am J Physiol Renal Physiol; 2020 May; 318(5):F1074-F1085. PubMed ID: 32150445
[TBL] [Abstract][Full Text] [Related]
5. Human recombinant relaxin-2 does not attenuate hypertension or renal injury but exacerbates vascular dysfunction in a female mouse model of SLE.
Wolf VL; Phillips TL; Taylor EB; Sasser JM; Ryan MJ
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H234-H242. PubMed ID: 31125285
[TBL] [Abstract][Full Text] [Related]
6. Preventing autoimmunity protects against the development of hypertension and renal injury.
Mathis KW; Wallace K; Flynn ER; Maric-Bilkan C; LaMarca B; Ryan MJ
Hypertension; 2014 Oct; 64(4):792-800. PubMed ID: 25024282
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure and albuminuria in a female mouse model of systemic lupus erythematosus: impact of long-term high salt consumption.
Dent EL; Broome HJ; Sasser JM; Ryan MJ
Am J Physiol Regul Integr Comp Physiol; 2020 Oct; 319(4):R448-R454. PubMed ID: 32813539
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD3 antibody therapy attenuates the progression of hypertension in female mice with systemic lupus erythematosus.
Mathis KW; Taylor EB; Ryan MJ
Pharmacol Res; 2017 Jun; 120():252-257. PubMed ID: 28400152
[TBL] [Abstract][Full Text] [Related]
9. High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice.
Starke C; Frey S; Wellmann U; Urbonaviciute V; Herrmann M; Amann K; Schett G; Winkler T; Voll RE
Eur J Immunol; 2011 Jul; 41(7):2107-12. PubMed ID: 21484784
[TBL] [Abstract][Full Text] [Related]
10. Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors.
Taddeo A; Khodadadi L; Voigt C; Mumtaz IM; Cheng Q; Moser K; Alexander T; Manz RA; Radbruch A; Hiepe F; Hoyer BF
Arthritis Res Ther; 2015 Mar; 17(1):39. PubMed ID: 25889236
[TBL] [Abstract][Full Text] [Related]
11. Expansion of regulatory T cells using low-dose interleukin-2 attenuates hypertension in an experimental model of systemic lupus erythematosus.
Taylor EB; Sasser JM; Maeda KJ; Ryan MJ
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1274-F1284. PubMed ID: 30892934
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors.
Alexander T; Cheng Q; Klotsche J; Khodadadi L; Waka A; Biesen R; Hoyer BF; Burmester GR; Radbruch A; Hiepe F
Eur J Immunol; 2018 Sep; 48(9):1573-1579. PubMed ID: 29979809
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus.
Venegas-Pont M; Manigrasso MB; Grifoni SC; LaMarca BB; Maric C; Racusen LC; Glover PH; Jones AV; Drummond HA; Ryan MJ
Hypertension; 2010 Oct; 56(4):643-9. PubMed ID: 20696988
[TBL] [Abstract][Full Text] [Related]
14. Curcumin attenuates autoimmunity and renal injury in an experimental model of systemic lupus erythematosus.
Dent EL; Taylor EB; Turbeville HR; Ryan MJ
Physiol Rep; 2020 Jul; 8(13):e14501. PubMed ID: 32652896
[TBL] [Abstract][Full Text] [Related]
15. Hypertension in an experimental model of systemic lupus erythematosus occurs independently of the renal nerves.
Mathis KW; Venegas-Pont M; Flynn ER; Williams JM; Maric-Bilkan C; Dwyer TM; Ryan MJ
Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R711-9. PubMed ID: 23926131
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib treatment induces a higher mortality rate in lupus model mice with a higher disease activity.
Ikeda T; Fujii H; Nose M; Kamogawa Y; Shirai T; Shirota Y; Ishii T; Harigae H
Arthritis Res Ther; 2017 Aug; 19(1):187. PubMed ID: 28800777
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.
Cheng Q; Mumtaz IM; Khodadadi L; Radbruch A; Hoyer BF; Hiepe F
Ann Rheum Dis; 2013 Dec; 72(12):2011-7. PubMed ID: 24114925
[TBL] [Abstract][Full Text] [Related]
18. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
[TBL] [Abstract][Full Text] [Related]
19. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
Starke C; Steinkasserer A; Voll RE; Zinser E
Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress promotes hypertension and albuminuria during the autoimmune disease systemic lupus erythematosus.
Mathis KW; Venegas-Pont M; Masterson CW; Stewart NJ; Wasson KL; Ryan MJ
Hypertension; 2012 Mar; 59(3):673-9. PubMed ID: 22291449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
